Cancellation of Registration/Listing/Inclusion of Goods in the Australian Register of Therapeutic Goods - 25 June 2013

Overview

The Therapeutic Goods Act 1989 was enacted to regulate the provision of therapeutic goods in Australia, ensuring they are safe, of high quality, and that their benefits outweigh any risks. The Act was introduced to address the need for a comprehensive framework governing the approval, registration, and monitoring of therapeutic goods to protect public health. The Therapeutic Goods Administration, acting on behalf of the Commonwealth Government, is responsible for enforcing this Act. One of the key policy objectives of the Act is to maintain a robust system for the registration of therapeutic goods, including the ability to cancel listings for non-compliance, such as the failure to pay annual charges. This legislative measure helps to uphold the integrity and safety standards of therapeutic goods available in the Australian market.

Scope and Application

The Therapeutic Goods Act 1989 applies to a wide range of therapeutic goods, including medicines, medical devices, blood and blood components, tissues, and in vitro diagnostic goods. This Act applies to entities that sponsor or manufacture these goods, as well as those that import, supply, or otherwise deal with them within Australia. The Act’s jurisdictional reach is nationwide, encompassing the Commonwealth, states, and territories. Its purpose is to regulate the quality, safety, and efficacy of therapeutic goods to protect public health. Exclusions and exemptions may apply to certain goods under specific conditions, such as for research or clinical trials, but these are narrowly defined and subject to approval. The Act also allows for the extension or restriction of its application through subordinate instruments, such as regulations or guidelines, which provide further detail on the implementation of the Act's provisions.

Key Provisions

The Therapeutic Goods Act 1989, specifically under Section 41GL(f), outlines the process for cancelling the registration, listing, or inclusion of therapeutic goods in the Australian Register of Therapeutic Goods (ARTG). In this instance, the entries for certain goods have been cancelled due to the failure of the sponsors to pay the annual charges within the required timeframe of 20 days after they became due. The goods that were cancelled include various lenses, spectacle products, and ear candles, all listed under the respective sponsor names and ARTG numbers provided. For the parties or entities governed by the Therapeutic Goods Act 1989, the obligations and requirements include maintaining the payment of annual charges for the registration or listing of goods in the ARTG. Failure to do so within the stipulated period results in the cancellation of the entries. This requirement ensures that the register remains current and accurate, reflecting only those goods for which active sponsorship and compliance with the Act's provisions are maintained. Sponsors must be vigilant in managing their financial obligations to avoid such cancellations, which can impact their ability to market and sell their products in Australia. The Act imposes consequences for breaches of its provisions. In this case, the failure to pay annual charges within the required timeframe leads to the cancellation of the entries in the ARTG. While the Gazetted notice does not specify the exact penalties for such breaches, the Therapeutic Goods Act 1989 generally provides for both civil and criminal penalties. Civil penalties can include fines, and in more severe cases, criminal penalties may apply, potentially leading to imprisonment. The specific penalties would depend on the nature and extent of the breach, and the discretion of the court when dealing with civil or criminal proceedings.